Dossier,Guideline,PDF link,type of study,429_observations and recording of toxicity,429_stimulation index (SI),429_ATP measurments,429_relative luminecence units (RLU),429_BrdI labelling index,429_erythema scores,ear thickness,429_conclusion,429_homogeneity,429_pH,429_physical form,429_concentration (%),429_composition,429_purity (%),429_solubility in vehicle,429_chemical batch nr,429_additional info,429_species/strain,429_source,429_age at start of experiment,429_sex,429_feed,429_n animals / group,429_deviation from guideline,429_dose levels,429_volume,429_administration scheme,429_vehicle,429_year,429_GLP,429_SCCS comment to test,429_Ref. in dossier,429_control group,429_preliminary test,429_additional information,429_own comments
"1,2,4-trihydroxybenzene ",429,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_113.pdf,in vivo,"no clinical signs and no mortality related to treatment were observed during the study. in the first experiment, dryness of the skin was noted on day 6 in 2/4 and 4/4 animals given 1,2,4-trihydroxybenzene at the concentrations of 1 and 2.5%, respectively. in addition, a moderate increase in ear thickness shows the irritant potential of 1,2,4-trihydroxybenzene at mentioned concentrations. no cutaneous reactions and no noteworthy increases in ear thickness were observed in the second experiment. in the first experiment, positive lympho-proliferative responses were observed at all tested concentrations but without clear evidence of a dose-response relationship. in the absence of local irritation, the positive responses observed at the concentrations of 0.25 and 0.5% were attributed to delayed contact hypersensitivity. ",exp 1: ranged from 12.68 to 26.41 using concentrations in the range from 0.25 to 5%/ exp 2 :  a dose related increase in the stimulation indices (except at 0.1%) was noted and the threshold positive value of 3 was exceeded at the concentration of 0.25%.,,,,,exp 1: moderate increase (up to 45%) at the concentrations of 2.5 and 5%,"1,2,4-trihydroxybenzene induced delayed contact hypersensitivity in the murine LLNA.  the EC3 value for the 1,2,4-trihydroxybenzene calculated on the basis of the results obtained in the second experiment is equal to 0.08%.  accordingly,  1,2,4-trihydroxybenzene should be categorised as an extreme sensitizer. ",,,,,,98.1,,506382,,mice/CBA/J,,,,,4,,"experiment 1: 0.25, 0.5, 1, 2.5 or 5% (w/v) in DMF; experiment 2: 0.01, 0.05, 0.1, 0.25 or 0.5% ",,daily for 3 consecutive days,dmf,,yes,,5,,,"applied volume: 25 µl per ear,  after 2 days of resting, the proliferation  of the lymph node cells was measured by incorporation of tritiated methyl thymidine. scoring on days 1,2,3 and 6 ",
vetiveryl acetate ,OECD TG 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,in vivo,"no erythema or oedema was noted in any of the mice at any time during the study, except positive control. there were no statistically significant differences in mean body weights at day 1 and day 6 or in mean body weight changes. the lymph nodes from all mice treated with the test substance at 25% and with HCA at 35% were enlarged, but otherwise appeared normal. ","0, 1.67, 1.90, 2.53, 3.33, 10.09",,,,,,vetiveryl acetate exhibited a potential to induce dermal sensitisation in this murine local lymph node assay. these materials are considered weak to moderate dermal sensitisers. EC3: 9.3% (2317 μg/cm2),,,light yellow liquid,"0, 1, 2.5, 5, 10, 25%",,,,203938,test substace: acetyver 230451,mouse/CBA/J,,,f,,5,"on day 6 intravenous injection in tail with 20 microCurie of radiolabelled 3H-thymidine in sterile saline.  the mice were killed by CO2 asphyxiation 5 hours later.  a single cell suspension was prepared by pooling the lymph nodes from each group. after washing twice with phosphate buffered saline, cells were precipitated overnight at 2-8°C with 5% trichloroacetic acid. incorporation of 3H-thymidine was measured in a β-scintillation counter. ",,,topical application once daily for three consecutive days ,diethyl phthalate/ethanol in a 3:1 ratio,2007,yes,moderate skin sensitisers,79,"the negative control groups were treated with the vehicle alone. a positive control, hexylcinnamaldehyde (HCA), was included in the llna with test substance D and was used at the positive control for the three other llna run concurrently with this study. very slight erythema on day 2 in one mouse treated with 35% HCA and on day 3 in all 5 mice treated with 35% HCA. ",,,
vetiveryl acetate ,OECD TG 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,in vivo,"3 dead animal ( no gross lesions were found upon necropsy and the cause of dead was unknown), no erythema or oedema was noted in any of the mice at any time during the study. there were no statistically significant differences in mean body weights at day 1 and day 6 or in mean body weight changes. the lymph nodes from all mice treated with the test substance at 25% and with HCA at 35% were enlarged, but otherwise appeared normal. ","0, 1.59, 0.88, 2.00, 2.18, 15.93",,,,,,vetiveryl acetate exhibited a potential to induce dermal sensitisation in this murine local lymph node assay. these materials are considered weak to moderate dermal sensitisers. EC3: 10.9% (2722 μg/cm2),,,yellow liquid,"0, 1, 2.5, 5, 10, 25%",,,,9000669418,test substace: acet vetivenyl E 112 Extra,mouse/CBA/J,,,f,,5,"on day 6 intravenous injection in tail with 20 microCurie of radiolabelled 3H-thymidine in sterile saline.  the mice were killed by CO2 asphyxiation 5 hours later.  a single cell suspension was prepared by pooling the lymph nodes from each group. after washing twice with phosphate buffered saline, cells were precipitated overnight at 2-8°C with 5% trichloroacetic acid. incorporation of 3H-thymidine was measured in a β-scintillation counter. ",,,topical application once daily for three consecutive days ,diethyl phthalate/ethanol in a 3:1 ratio,2007,yes,moderate skin sensitisers,80,"the negative control groups were treated with the vehicle alone. a positive control, hexylcinnamaldehyde (HCA), was included in the llna with test substance D and was used at the positive control for the three other llna run concurrently with this study.  a very slight erythema on day 2 in one mouse treated with 35% HCA and on day 3 in all 5 mice treated with 35% HCA",,,
vetiveryl acetate ,OECD TG 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,in vivo,"no erythema or oedema was noted in any of the mice at any time during the study,  there were no statistically significant differences in mean body weights at day 1 and day 6 or in mean body weight changes. the lymph nodes from all mice treated with the test substance at 25% and with HCA at 35% were enlarged, but otherwise appeared normal. ","0, 1.15, 1.49, 2.29, 2.23, 5.73",,,,,,vetiveryl acetate exhibited a potential to induce dermal sensitisation in this murine local lymph node assay. these materials are considered weak to moderate dermal sensitisers. EC3 : 13.3%(3325 μg/cm2) ,,,light yellow liquid,"0, 1, 2.5, 5, 10, 25%",,,,B,test substace: vetiveryl acetate EX Haiti Clos Ha,mouse/CBA/J,,,f,,5,"on day 6 intravenous injection in tail with 20 microCurie of radiolabelled 3H-thymidine in sterile saline.  the mice were killed by CO2 asphyxiation 5 hours later.  a single cell suspension was prepared by pooling the lymph nodes from each group. after washing twice with phosphate buffered saline, cells were precipitated overnight at 2-8°C with 5% trichloroacetic acid. incorporation of 3H-thymidine was measured in a β-scintillation counter. ",,,topical application once daily for three consecutive days ,diethyl phthalate/ethanol in a 3:1 ratio,2007,yes,moderate skin sensitisers,81,"the negative control groups were treated with the vehicle alone. a positive control, hexylcinnamaldehyde (HCA), was included in the llna with test substance D and was used at the positive control for the three other llna run concurrently with this study. a very slight erythema on day 2 in one mouse treated with 35% HCA and on day 3 in all 5 mice treated with 35% HCA. ",,,
vetiveryl acetate ,OECD TG 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,in vivo,"1 dead animal ( no gross lesions were found upon necropsy and the cause of dead was unknown), no erythema or oedema was noted in any of the mice at any time during the study, there were no statistically significant differences in mean body weights at day 1 and day 6 or in mean body weight changes. the lymph nodes from all mice treated with the test substance at 25% and with HCA at 35% were enlarged, but otherwise appeared normal. ","0, 0.85, 0.93, 1.52, 1.12, 10.18",,,,,,vetiveryl acetate exhibited a potential to induce dermal sensitisation in this murine local lymph node assay. these materials are considered weak to moderate dermal sensitisers. EC3: 13.1% (3277 μg/cm2),,,yellow liquid,"0, 1, 2.5, 5, 10, 25%",,,,1590849,test substace: ROB HB,mouse/CBA/J,,,f,,5,"on day 6 intravenous injection in tail with 20 microCurie of radiolabelled 3H-thymidine in sterile saline.  the mice were killed by CO2 asphyxiation 5 hours later.  a single cell suspension was prepared by pooling the lymph nodes from each group. after washing twice with phosphate buffered saline, cells were precipitated overnight at 2-8°C with 5% trichloroacetic acid. incorporation of 3H-thymidine was measured in a β-scintillation counter. ",,,topical application once daily for three consecutive days ,diethyl phthalate/ethanol in a 3:1 ratio,2007,yes,moderate skin sensitisers,86,"the negative control groups were treated with the vehicle alone. a positive control, hexylcinnamaldehyde (HCA), was included in the LLNA with test substance D and was used at the positive control for the three other LLNA run concurrently with this study. a very slight erythema on day 2 in one mouse treated with 35% HCA and on day 3 in all 5 mice treated with 35% HCA.",,,
resorcinol,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_015.pdf,in vivo,"lymphoproliferative responses observed in negative control groups fell within historical ranges, while significant lymphoproliferation was observed with α-hexylcinnamaldehyde at 25% ( positive control), thus validating the sensitivity of the test system and procedure used. no mortality and no clinical signs were observed in the first experiment. in the second experiment, hypoactivity, piloerection and dyspnoea were observed on day 3 in 1/4 and 2/4 animals of the treated groups given 1% and 5%, respectively. no cutaneous reactions and no increase in ear thickness were observed at any tested concentrations.","experiment 1: 3.83, 4.14, 3.97, 3.51, 3.30, positive control 7.48 - experiment 2: 1.58, 2.87, 1.97, 3.51, 5.74, positive control 6.97",,,,,,"in the first experiment, positive lymphoproliferative responses (SI>3) were noted at all tested concentrations, but no clear dose-response relationship was observed. in the second experiment, a dose-related increase in SI was observed (except at the concentration of 1%) and the threshold positive value of 3 was exceeded at concentrations ≥ 5%. the EC3 value for this experiment was 1.4%. resorcinol induced contact sensitisation in this study",,,,,,98.8,,706030517,,mouse/CBA/J,,,f,,4,,"experiment 1: 2.5%, 5%, 10%, 25% and 50% and experiment 2: 0.1%, 0.5%, 1%, 5% and 25%",,once daily for 3 days,dimethylformamide,2004,yes,"according to the grading scheme used by the SCCS, resorcinol should be considered as a strong sensitiser.",4,,,"7 groups of 4 animals in two independent performed experiments. a preliminary test was performed in four (4) female mice to determine the irritant potential of the test compound. the maximum practicable, non-irritant concentration was found to be 50%.  dose volume: 25µl applied to the dorsal surface of both ears, administration of 250µl of 0.9%NaCl containing 20µCi of tritiated thymidine (3H-TdR) on day 6 for 5hours before excising auricular lymph nodes cell, cell proliferation measured by  β-scintillation counting, the left ear thickness measured on days 1,2,3 and 6",
"quinolinium, 4-formyl-1-methyl-, salt with 4-methylbenzene sulfonic acid (1:1)",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_080.pdf,in vivo,"no mortality was observed throughout the study period. no test item related clinical signs were observed in any animals of the control group, group2 (5%), or group 3 (10%). on the bthird application day, slight ear swelling was observed at both doing sites in all animals of group 4 (25%), persisting for the remainder of the in-life phase of the study.",,,,,,,"as indicated by SI, the test substance was not a sensitiser in LLNA",,,,"5.0, 10.0 and 25",,97.9,,SAT 990705,,mouse/CBA/CaOlaHsd,,,f,,4,,"5.0, 10.0 and 25%",,once daily for 3 consecutive days,"acetone:olive oil (4:1, V/V) ",,yes,,10,,,"pre-test (excluded from GLP compliance): to determine the highest non-irritant and technically applicable test item concentration, a non-GLP pre-test was performed in two mice with concentrations of 2.5%, 5%, 10% and 25% (w/v, in acetone:olive oil (4:1, v/v)). the top dose was the highest technically achievable concentration whilst avoiding systemic toxicity and excessive local irritation. no severe irritant effects were tolerated choosing the test concentrations. the test item in the main study was assayed in three consecutive concentrations. main study: animals treated with 25µl of three different test substance concentrations applied on the entire dorsal surface of each ear lobe once daily for 3 consecutive days. a hair dryer was used to dry the ears surface as quickly as possible after treatment. five days after the first topical application, all mice were administered with 250 µl of 78.68 µCi/ml 3HTdR by intravenous injection via a tail vein. five hours later, all mice were euthanized by intraperitoneal injection of VETANARCOL, and draining lymph nodes were rapidly excised and pooled for each experimental group. after preparing a single cell suspension for each mouse, cells were precipitated by TCA and the radioactivity was determined (incorporation of [H3] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm). ",
hydroxypropyl p-phenylenediamine and its dihydrochloride salt,"429, EC B.42",https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_230.pdf,in vivo,"in the preliminary assay, treated mice showed no sign of toxicity at the dose concentration of 1.0%, 5.0%, 10.0% and 25% (w/v). there was no noteworthy increase observed in ear thickness measurement. there were lymphoproliferative responses with SI values of 1.72, 2.35, 3.53, 15.97 and 19.2 obtained at hydroxypropyl p-phenylenediamine HCl concentrations of 1%, 2.5%, 5%, 10% and 25%, respectively. the threshold value of 3 for positive results was exceeded at 5%, and the EC3 value was calculated to be 3.88%. ","1.72, 2.35, 3.53, 15.97 and 19.2",,,,,,"under the conditions of this study, hydroxypropyl p-phenylenediamine HCl did induce delayed contact hypersensitivity. according to the EC3 value calculated (3.88%), hydroxypropyl pphenylenediamine HCl was considered to have a moderate sensitising potential.",,,,"1, 2.5, 5, 10, 25",,97.2 pure (relative purity was 98.6%), 25% (w/v) hydroxypropyl pphenylenediamine HCl was the maximal practicable concentration in the vehicle,R0025521B 004 P 001,,mouse/CBA/J ,,,,,"4 (main study), 2 (preliminary assay)",,"1, 2.5, 5, 10, 25%",,topical daily for 3consecutive days,propylene glycol,2012,yes,"the SCCS agrees with the applicant that hydroxypropyl p-phenylenediamine 2HCl is a moderate skin sensitiser. the applicant stated that there was no noteworthy increase in ear thickness, but this is not supported by the provided data that show an increase in ear thickness in all exposed mice. in the high-dose group an increase of 20% in ear thickness was reported. in view of this, the SCCS considers hydroxypropyl p-phenylenediamine 2HCl as slightly irritant under the conditions of this study. ","verma,2012",,,positive control: HCA at 25% (v/v) in propylene glycol. ,
picramic acid and sodium picramate,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_042.pdf,in vivo,"the calculated EC3 value for sodium picramate was 6.7% w/v. For the positive control, α-hexylcinnamaldehyde was 12.96%. therefore, sodium picramate is a skin sensitiser. ","0, 1.2, 2.7, 3.6, 7.9, 11.4",,,,,,"in the LLNA, sodium picramate is a moderate skin sensitiser",,,,"0, 1, 5, 10, 25 and 50",,62.6,,145/03,sodium picramate,mice/CBA/CaOlaHsd (nulliparous and non-pregnant) ,,,f,,4,,"0, 1, 5, 10, 25 and 50% w/v",,daily for 3 days,DMSO,2004,yes,,12,,,"positive control: α-hexylcinnamaldehyde (85% pure) (in acetone:olive oil; 4:1); 25µL test preparation applied to dorsal aspect of ear lobe for 3 days, 5 days after the first application 250µL of solution containing 81.3µCi/mL 3HTdR given by IV injection into tail vein. 4h later animals were killed to dissect the draining lymph nodes. incorporation of 3HTdR was measured by β-scintillation. α-hexylcinnamaldehyde 5% gave 0.87 SI, 10% 2.26 and 25% 6.01.",
phenylene bis-diphenyltriazine,OECD 429,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_215.pdf,in vivo,"the sensitising potential of wp30 was tested in a LLNA in mice using in vivo 5-bromo-20-deoxyuridine incorporation according to OECD 429, EC B.42, OPPTS 870.2600, EPA 712-C03-197 under GLP conditions. evaluation of local irritation was carried out in parallel. after a standard work-up procedure, the radioactivity was determined. the solubility of wp30 as suspension in AOO (3+1) was verified up to the investigated concentration of 10%. none of the three tested concentrations of the test item reached the stimulation index of 3. all animals survived throughout the test period without showing any clinical signs. all animals showed the excepted body weight gain, which includes a body weight reduction of up to 2 g throughout the study. results of radioactivity determination were supported by the means of the lymph node weights per group, which showed no significant difference compared to the negative control. the solubility of wp30 as suspension in AOO (3+1) was verified up to the investigated concentration of 10%. ","6.25% - SI 1.2, 12.5% - SI 0.9, 25%  - SI 1.1",,,,,,"under the experimental conditions, wp30 was shown to have no skin sensitising properties and should therefore not be considered as a dermal sensitiser.",,,,"25% (w/w) in AOO (preliminary test). 6.25%, 12,5%, 25% (w/w) in AOO (main test)",,99.6,,LP110,test substance: wp30. positive control: independent experiment with 1% p-phenylenediamine in AOO 3+1 (v/v) conducted in september 2009. negative control: vehicle alone (acetone/olive oil),mouse/cba/caolahsd,,8-9 weeks old,f,,5,,"6.25%, 12,5%, 25% (w/w) in AOO (main test)",,"once daily, topical application to dorsal surface of both ears on days 1,2 and 3.","AOO, 3+1 (v/v)",06 october 2009 - 5 november 2009,yes,"the sensitising potential of the active substance so2374 was tested in the LLNA using in vivo 3 H-methyl thymidine incorporation and not 5-bromo-20-deoxyuridine. the solubility of the active substance S02374 in AOO is poor. the test substance probably forms a stable dispersion in this vehicle and was prepared freshly on each day of application. due to the oily nature of the vehicle, SCCS assumes that the test substance, although not fully solubilised, will stick to the ears in the LLNA. S86 tested up to 25% is not considered as a skin sensitiser.","39, 65 (submission II)",,,"preliminary test: 3 animal preliminary concentration: 25% (w/w) in AOO. .taken from SCCS/1556/15. in the LLNA, the active (non-ground) substance S02374 was tested at concentrations of 6.25%, 12,5% and 25% in acetone/olive oil (AOO) and did not induce skin sensitisation. however, no data on the solubility of the test item in the vehicle AOO was provided and therefore the relevance of this study is unclear. in another LLNA, the cosmetic ingredient S02771 (containing 46.5% of the ground active substance in the suspension) was tested at concentrations of 6.25%, 12.5% and 25% and did not induce skin sensitisation. the test was performed with water as the vehicle. wholly aqueous vehicles should be avoided in the LLNA, because those vehicles are likely to run off the skin and the substance may not become bioavailable at all. thus, the relevance of this test is questionable. SCCS comment (SCCS/1556/15) In conclusion, both tests conducted on skin sensitisation are considered inconclusive and a skin sensitising potential of the active substance S02374 and the cosmetic ingredient S02771 cannot be excluded. new submission. no new skin sensitisation data were submitted, but the applicant provided novel information on the solubility of the non-ground active substance S02374 in AOO. this information was used to re-evaluate the LLNA study provided in Submission I. ",
phenylene bis-diphenyltriazine,OECD TG429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_184.pdf,in vivo,"all animals survived throughout the test period without showing any clinical signs. mean values of the stimulation indices were ≤ 1.2 for all three concentrations and no dose response relationship was seen. hence, none of the three tested concentrations of the test item reached the stimulation index of 3. all animals showed the accepted weight development, which includes a weight loss of up to 2 grams throughout the study. EC3 values (derived by linear interpolation) could not be calculated because the stimulation indices of all concentrations were below 3.",at 6.25%: 1.2; at 12.5%:0.9; at 25%: 1.1%,,,,,,"under the experimental conditions adopted, so2374 (batch No. LP110) at the doses tested is expected to have no sensitising properties and therefore should not be regarded as a dermal sensitiser.",,,,,,99.6,,LP110,test substance: cho222-wp30 (S02374 active substance),mice/cba/caolahsd,,8-9 weeks old,f,,5,,"preliminary test: 25% (w/w) in AOO, main test: 6.25%, 12.5%, 25% (w/w) in AOO",,daily for three consecutive days,acetone/olive oil 3+1,2009,yes,"no data on the solubility of the test item in acetone/olive oil (AOO), 3+1 (v/v) has been provided. thus, the relevance of the test cannot be assessed. the relevance of the studies provided is unclear therefore, a skin sensitising potential cannot be excluded.",59,,,"preliminary test: 3 animal per gourp. positive control: independent experiment with 1% p-phenylenediamine in AOO 3+1 (v/v conducted in september 2009, negative control: vehicle alone (acetone/olive oil),  based on a preliminary study using a concentration of 25 % (w/w) in AOO, no signs of toxicity or skin irritation were observed.",
phenylene bis-diphenyltriazine,OECD TG442B,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_184.pdf,in vivo,"amount of cells, cellularity index and stimulation index of so2771 at 6.25%, 12.5% and mainly at 25% were higher than the values found for the vehicle. stimulation index of so2771 6.25%, 12.5% and 25% were in the range of the values found for the vehicle. whatever the dose tested, so2771 did not produce a SI equal to or greater than 3. consequently, the EC3 value, defined as the theoretical concentration resulting in a SI value of 3, cannot be calculated for so2771. DNCB at 0.5% showed a statistically significant stimulation index of 3.3. DNCB at 0.5% induced a cellularity index of 5.3 with a total amount of viable cells per node of 17.9 x 106 compared to 3.4 x 106 with the vehicle control group. a statistically significant increase of 35% in ear thickness was observed on day 3 compared with the vehicle control group.",,,,,," at 6.25% (+13% on day 3), at 12.5% (+20% on day 3) and at 25% (+5% and +35%, respectively on day 2 and day 3) ","under the experimental conditions adopted, so2771 (batch No. LP110) at the doses tested did not induce delayed contact hypersensitivity in the murine LLNA using CBA/J Rj female mice after three consecutive days of treatment.",,4.11,,"6.25%, 12.5%, and 25% ",,99,,LP110,"test substance: so2771 yellow suspension, content of the ground active substance 46.5",mice/cba/j rj stain,,,,,4,,"6.25%, 12.5%, and 25% (w/w)",,,water for injection,2011,yes (main test only),"unusual for a GLP study, the date of the experimental phase of the study is not given in the study report. the study was conducted according to the OECD TG 442B using BrdU ELISA to measure lymphocyte proliferation (July 2010). therefore, an SI of 1.6 instead of 3 should have been used as criterion for a sensitisation potential. according to OECD TG 442B, wholly aqueous vehicles should be avoided in the LLNA, because those vehicles are likely to run off the skin. thus the relevance of the test is questionable. In principal, in such a case, a vehicle that contains a solubiliser (e.g. 1% Pluronic®L29) may be used.  the relevance of the studies provided is unclear therefore, a skin sensitising potential cannot be excluded.",,,,"preliminary test: 4, negative control: vehicle alone (water), positive control: DNCB at the concentration of 0.5% AOO, 4:1, v/v, compared with a vehicle control group (AOO); the concentrations were based on the results of a preliminary study in which no effect on ear thickness was seen at any dose and no local reaction was seen after application of so2771 at 6.25%, 12.5% and 25%, however rigid ears were observed in animals treated at 50% on day 3 and day 4. all animals of all groups received a single intraperitoneal injection of 250 μL of 0.9% sodium chloride containing 2.5 mg of BrdU. ELISA system is used. ",
methylimidazoliumpropyl p-phenylenediamine HCl ,OECD 429,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_231.pdf,in vivo,a SI value of 8.04 was obtained with the positive control HCA. the threshold value of 3 for positive results was exceeded at 5% with a dose-response effect ,"2.69, 7.99, 10.77, 12 and 15.91 at 1%, 5%, 10%, 25% and 50% respectively",,,,,,"all validity criteria were fulfilled and the study was therefore considered to be valid. under the conditions of this study, methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166) induced delayed contact hypersensitivity. according to the EC3 value calculated (1.23%), methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166) was considered to have a moderate sensitising potential. ",,,,"1, 5, 25 and 50% (w/v)",,>95,"due to unsatisfactory solubility tests with several recommended vehicles, pluronic L-92 was selected on the basis of a solubility study revealing 50% (w/v) methylimidazoliumpropyl pphenylenediamine, Cl, 2HCl (A166) as the maximal technically feasible concentration. ",R0027494A 002 L 001,"test substance: methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166).",mouse/ CBA/J,,,f,,4 (main study) 2 (preliminary assay),,,,"applied on the ears (25 µL per ear) of mice for three consecutive days designated as days 0, 1 and 2. After 2 days of resting (day 5), mice received a single intravenous injection of tritiated methyl thymidine (3 H-TdR).",pluronic® L92 1% in water ,2012,yes,"SCCS considers methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166) as a strong skin sensitiser, based on the EC3 value of 1.23% observed in the LLNA (see SCCP, 2005)",verma 2012,,,positive control: alpha-hexylcinnamaldehyde (HCA) 25%(v/v) in water with 1% pluronic® L92. vehicle control: pluronic® L92 1% in water,
hydroxyethyl-2-nitro-p-toluidine,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_061.pdf,in vivo,there were no clinical signs or deaths. Minor body weight loss (in fewer than 10% animals) was not considered to be treatment related. the mean stimulation index was not affected by hydroxyethyl-2-nitro-p-toluidine treatment at any concentration or by either vehicle. hydroxyethyl-2-nitro-p-toluidine did not induce a biologically relevant immune response at any concentration with either vehicle and the stimulation index at each concentration was comparable with the vehicle controls. the EC3 could not be calculated as the stimulation index was below 3. ,positive control PPD 1%: (DMSO: SI 12.5; water/acetone/olive oil: SI /); hydroxyethyl-2-nitro-p-toluidine 0.5%: (DMSO: SI 1.1; water/acetone/olive oil: SI 1.3); hydroxyethyl-2-nitro-p-toluidine 1.5%: (DMSO: SI 1.4; water/acetone/olive oil: SI 1.0); hydroxyethyl-2-nitro-p-toluidine 5.0%: (DMSO: SI 1.0; water/acetone/olive oil: SI 1.3); hydroxyethyl-2-nitro-p-toluidine 10.0%: (DMSO: SI 0.9; water/acetone/olive oil: SI 1.0),,,,,,the study authors did not consider hydroxyethyl-2-nitro-p-toluidine as a skin sensitizer under these test conditions. ,,,,,,99.8 (HPLC at 254nm),10.0% (equal to maximum solubility) ,6718 fass 10/20 ,,mice/ CBA/J,,,f,,5,," 0, 0.5, 1.5, 5.0 and 10.0% (w/v)",,,DMSO or water/acetone (1:1) mixed with olive oil (3:1) ,2004,yes,"the highest concentration tested (10%) was too low for hazard identification. therefore, a sensitising potential cannot be excluded. in submission 1, a magnusson-kligman study in guinea pigs was reported. intradermal topical induction with 0.5% hydroxyethyl-2-nitro-p-toluidine in water and challenge at 0.25% were performed. slight erythema was observed at challenge (1/20 test animals; 2/20 controls) while no primary skin irritation occurred. hydroxyethyl-2-nitro-p-toluidine was not considered a skin sensitizer under these test conditions.(ref 7, submission I)","17, submission III",,,"positive control: p-phenylenediamine (1% in DMSO). dose volume: 25µl, animals were checked daily before and after dosing for clinical signs and morbidity or death. body weight was checked on day –1 and 5. On day 5, the mice were given an intravenous injection (phosphate buffer with 23.9 µCi 3H methyl thymidine). five hours later, all mice were killed by CO2 inhalation and the draining lymph nodes were rapidly weighed. after preparing a single cell suspension for each mouse, cells were precipitated by TCA and the radioactivity was determined (incorporation of [3H] methyl thymidine in the pellets) bymeans of liquid scintillation counting as disintegration per minute (dpm). the mean dpm was determined and the stimulation index was calculated, comparing with concurrent vehicle controls. ",
"n,n’-bis-(2-hydroxyethyl)-2-nitro-p-phenylenediamine",OECD 429,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_196.pdf,in vivo,slight skin irritation was noted on the ear dorsum of the treated mice at a concentration of 10% (w/v). the Stimulation Index (S.I.) was below 3 in all dose groups. no dose response relation was noted. the EC3 value was not calculated because no test concentrations produced a S.I. of 3 or higher. the EC3 value for the positive control was 11.7% w/v. ,,,,,,,"a higher concentration of b034 than 10% (w/v) in acetone:olive oil could not be used because of irritation. therefore, b034 at more than 10% is assumed to have irritant potential. b034 was not determined to be a skin sensitiser under these particular experimental conditions",,,,,,99.5,,dala 013106 (sat 040271),test substance: b034,mouse/ bs/caolahsd (nulliparous and non-pregnant),,,f,,4,,"0, 2.5, 5, 10% (w/v) (application volume 25 µl)",,once daily for three consecutive days,"acetone:olive oil, 4:1 (v/v)",2004,yes,,"6, submission II",,,"positive control: α-hexylcinnamaldehyde (march 2004); acetone:olive oil, 4:1 (v/v). the highest non-irritating and technically applicable test item concentration was found in a pre-test with two mice. topical (epidermal) application to the dorsal surface of each ear lobe (left and right), spread over the entire dorsal surface of each ear lobe. five days after the first topical application, all mice were administered with radio-labelled thymidine (³HTdR) by intravenous injection via the tail vein. approximately five hours after ³HTdR application, the draining lymph nodes were excised and pooled for each experimental group. after preparation of the lymph nodes, disaggregation and overnight precipitation of macromolecules, these precipitations were resuspended and transferred to scintillation vials. level of ³HTdR incorporation was then measured by scintillation counting. the proliferative response of lymph node cells is expressed as the ratio of ³HTdR incorporation into lymph node cells of treated animals relative to that recorded in control mice (stimulation index). the proliferative capacity of pooled lymph node cells was determined by quantifying the incorporation of ³H-methyl thymidine.",
methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (S87),OECD 442B,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_227.pdf,in vivo,"no clinical signs, including skin irritation at the application area, were observed in any animal in the test item-treated or vehicle control group. no appreciable body weight changes were observed. in the positive control group, very slight erythema was observed in both ear auricles of all animals at approximately 1 hour after application on days 2 and 3 only.","SI values were 1.1, 1.0 and 1.0 in the low-, mid- and high-dose groups (10, 25 and 50% (w/v)), respectively. SI value in the positive control group was 7.4, indicating a positive response and an adequate sensitivity of the test system",,,,,,"c-1701 b_c_3 in dmf was considered not to possess any skin sensitising potential under the experimental conditions employed. therefore, c-1701 b_c_3 is not considered to be a skin sensitiser",,,,"10, 25, 50",,100,,1442/3+4,test substance: c-1701 b_c_3 ,mouse/ cba/j ,,,f,,2 animals/group (pre-test); 5 animals/group (main test),,"10, 25 and 50 w/v%",,once daily to the outside of both ears (25 μL/ear) for three consecutive days,dmf,2012,yes,"the LLNA:BrdU-ELISA uses a different cut-off than the traditional LLNA. in this nonradioactive LLNA, a substance is considered a skin sensitiser when the SI ≥ 1.6 (OECD TG442B). however, using this criterion, S87 can still be regarded as having no skin sensitisation potential",25,,,"positive control: 25 vol % α-hexyl cinnamic aldehyde (HCA). the concentrations used for the main test were based on a preliminary study using concentrations of 10, 25 and 50% (w/v), in which no clinical signs and no appreciable changes in body weights or auricular thickness were noted.on day 5, Bromodeoxyuridine (BrdU) was administered intraperitoneally (i.p.) to all animals at a dose level of 5 mg/animal. all animals were sacrificed on day 6.the ears were observed and scored for erythema and/or edema. then the auricular lymph nodes were excised  for lymph node weight determination and for subsequent assessment of BrdU incorporation by means of flow cytometry. the number of BrdU- positive cells was calculated for each animal by multiplying the lymphocyte count by the ratio of BrdU-positive lymphocytes and the stimulation index (SI) was calculated for each treated group. ",
hydroxyethoxyphenyl butanone ,OECD 429,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_225.pdf,in vivo,positive control HCA generated a SI value of 3.38. the test substance induced a small increase in lymphoproliferation,"1.16, 1.24, 1.43, 1.53 and 1.78 (test substance concentrations respectively 1%, 10%, 25%, 50% and 75%)",,,,,,did not induce skin sensitisation in the LLNA,,,,"1, 10, 25, 50 or 75% (w/v)",,95.9 ± 0.5%,,r0069279a 019 d 004,test substance: r0069279a ,"mouse, cba/j",,,f,,4,,"1, 10, 25, 50 and 75 %",,daily on the dorsum of both ears for 3 consecutive days on the dorsum of both ears,acetone:olive oil (4:1; v/v),2011,yes,HEPB induced a dose-dependent increase of lymphocyte proliferation in the LLNA that resulted in a SI value of 1.78 at the highest dose (75%) tested. HEPB is not considered to be a skin sensitiser under the conditions of the test.,6,,,"guideline: ec b.42; positive control: α-hexylcinnamaldehyde (HCA) at 25 % (v/v) in AOO. concentrations for the main study were based on findings from a preceding irritation test, in which no increase in skin thickness was noted at test item concentrations of 5.0, 25.0, 50.0 and 75.0 % (w/v). after a 2-day rest, lymphocyte proliferation was assessed in the pooled auricular lymph nodes by measuring the incorporation of 3H-TdR. the values were used to calculate stimulation indices (SI)",
hc yellow n°9,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_026.pdf,in vivo,the stimulation index was lower than 3 at all the five concentrations assayed. no dose related effect was observed. hc yellow n° 9 at concentrations up to 1% did not induce delayed contact hypersensitivity in the murine local lymph node assay. no cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups.,at 0.05%: SI 1.15/ at 0.1% : SI 1.20/ at 0.25%: SI 1.12/ at 0.5%: SI 1.73/ at 1%: SI 1.12/ postive control: SI 16.02,,,,,,,,,,,,98.5,,510071,test substance: hc yellow n°9,mouse/cba/j ,,,f,,4,,"0.05, 0.1, 0.25, 0.5 and 1% in dmso",,"during the induction phase, the test item, vehicle or reference item was applied over the ears (25 μL per ear) for 3 consecutive days (days 1, 2 and 3). after 2 days of resting, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). the obtained values were used to calculate stimulation indices (SI). the irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6. α-hexylcinnamaldehyde (HCA) at the concentration of 25% in DMSO has been used as positive control.",dmso,2005,yes,the concentrations tested were too low. a sensitisation potential cannot be excluded.,4 (subm. 3) ,,,"positive control: hca at the concentration of 25% in dmso. local lymph node assay (llna), during the induction phase, the test item, vehicle or reference item was applied over the ears (25 μL per ear) for 3 consecutive days (days 1, 2 and 3). after 2 days of resting, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). the obtained values were used to calculate stimulation indices (SI). the irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6",
hc yellow n° 17 (b121),OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_186.pdf,in vivo,"mild local irritation was observed using the highest concentrations of hc yellow no.17. SI’s higher than 3 were observed for the test concentrations at and above 1 (4.3 for 1% to 19.7 for 50%) suggesting a high sensitising potency. because an EC3 could not be calculated, the second experiment with lower concentrations of hc yellow no.17 was conducted. based on the calculated EC value of 0.7% once solutions of 2,5%, 1%, 0,5%, 0,25% and 0,1% w/v were used, it was concluded that hc yellow no.17 has sensitising potential. the validity criteria were fulfilled in both. SI values of 9.1 and 6.1 were obtained with the positive control HCA in the first and second experiments, respectively. the lymphoproliferative responses were observed at all concentrations tested in the first experiment. it was attributed to delayed contact hypersensitivity in the absence of excessive local irritation",,,,,,,"under the conditions of this study, hc yellow no. 17 induced delayed contact hypersensitivity. according to the calculated EC3 value (0.7%), hcd yellow no. 17 was considered to have a sensitising potential.",,,,"1, 5, 10, 25 and 50% (w/v) in dimethylformamide (DMF)",,"relative purity 93.7% at 265 nm, 95.5% at 428 nm",the test concentrations were selected according to a previous study of solubility showing 50% as the maximum concentration of hc yellow no.17 possible when using dmf as vehicle.,E212289 BCF-52281/5,test substance: hc yellow no 17. ,mice/cba/jrj,,,f,,64,,"first experiment, the item solution was tested at concentrations of 50%, 25%, 10%, 5% and 1% w/v. second experiment : 2,5%, 1%, 0,5%, 0,25% and 0,1% w/v. ",,three consecutive days,the vehicle (dmf) alone and the relevant vehicle for hca (aoo) ,2012,yes,"under the conditions used in this study, hc yellow no. 17 is considered as a strong sensitiser capable of inducing delayed contact hypersensitivity. ",4,,,"positive control: hca at 25% (v/v) in a mixture acetone/olive oil (4/1, v/v), thereafter designated as aoo. local lymph node assay. in order to evaluate the skin sensitisation potential of the item e212289, two consecutive studies based on the local lymph node assay were conducted. the difference between the studies was the concentrations of the item solutions that were assessed. two studies were necessary to get conclusive results of the sensitisation potential of hc yellow no. 17. in both studies cba/ female mice were used. both ears were treated with hc yellow no.17 at different concentrations diluted in n,n-dimethylformamide (dmf). in the first experiment, the item solution was tested at concentrations of 50%, 25%, 10%, 5% and 1% w/v. these concentrations were selected according to a previous study of solubility showing 50% as the maximum concentration of hc yellow no.17 possible when using dmf as vehicle. the concentrations of the solutions tested in the second experiment were 2,5%, 1%, 0,5%, 0,25% and 0,1% w/v. the solutions were applied for three consecutive days. alpha-hexylcinnamaldehyde was used as positive control.",
hc red n° 7,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_007.pdf,in vivo,the EC3 for hc red nº 7 is equal to 1.2% ,"1.83, 2.54, 6.02, 3.19, 3.90, 11.98 at respectively 0.5, 1, 2.5, 5, 10% and pos. control",,,,,,moderate skin sensitizer,,,,,,99.3,10% of test substance is the maximum practicable concentration due to limited,510149,,mouse/cba/j (nulliparous and non-pregnant),,,f,,4,,"0, 0.5, 1, 2.5, 5 and 10%",,,"acetone:olive oil (4:1, v/v)",2004,yes,"according to the classification scheme applied by the SCCS (SCCP/0919/05), the substance is a strong sensitizer",4,,,positive control: α-hexylcinnamaldehyde (25%),
"1,5-naphthalenediol",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_033.pdf,in vivo,"EC3 value of 3.4% was calculated, based on data from the two experiments.","experiment 1: 18.4, 16.7, 6.1; experiment 1: 1.4, 2.5, 2.8 ",,,,,,moderate skin sensitiser,,,,,,99.9,,820211/01,"test substance: a018 / sat 030627 (1,5-naphthalenediol) ",mouse/cba/j,,,f,,5,,"experiment 1: 25 µl of a018 at 5, 25 and 50% n vehicle ; experiment 2: 25 µl of a018 at 0.25, 1.0 and 2.5% in vehicle",,"daily, for 3 consecutive days",acetone/olive oil (4:1 v/v),,yes,,7,,,"positive control: alpha-hexylcinnamaldehyde. during the induction phase, test item was applied over the dorsal surface of each ear (25 µl per ear) for 3 consecutive days (days 1, 2, 3). on day 6, each animal was administered with radio-labelled thymidine (3 HTdR) by intravenous injection. after 5 hours, animals were euthanized and the draining lymph nodes were excised and pooled to prepare single cell suspension for each animal. 3 HTdR incorporation was measured by scintillation counting. proliferative response of lymph node cells was expressed as the ratio of 3 HTdR incorporation into lymph node cells of treated animals relative to that recorded in control animals",
"1-hexyl 4,5-diamino pyrazole sulfate",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_181.pdf,in vivo,"none of the animals died during the study, bodyweights were not altered and all animals appeared clinically normal throughout the study. some orange staining on the ears and on the fur occurred, which was considered to be related to the staining properties of 4,5-diamino-1-hexyl-1H-pyrazole dihydrochloride. no treatment-related effects on bodyweight or bodyweight gain. 4,5-diamino-1-hexyl-1H-pyrazole dihydrochloride was positive in the llna, as there was a statistically significant increase in isotope incorporation in the draining auricular lymph nodes relative to the vehicle at 10% and 15%, which were greater than a 3-fold increase","0.7, 1.0, 3.5 and 3.1 at the concentrations of 1%, 3%, 10% and 15%, respectively",,,,,,"4,5-diamino-1-hexyl-1H-pyrazole dihydrochloride is a moderate skin sensitiser under the defined experimental conditions, with a calculated EC3 value of 8.6%. calculation for the hemisulfate salt of 1-hexyl-1H-pyrazole-4,5-diamine: the EC3 value of the hemisulphate salt was calculated from the dihydrochloride salt by using the conversion factor of 0.91 to account for the different molecular weight (see reference 20). EC3 value dihydrochloride: 8.6% 8.6% = 8.6 g/100 mL x 0.91 (conversion factor) = 7.8 g /100 mL = 7.8% EC3 value hemisulfate: 7.8%. therefore, the calculated EC3 value for 1-hexyl-1H-pyrazole-4,5-diamine hemisulfate is 7.8%. based on this calculation, 1-hexyl-1H-pyrazole-4,5-diamine hemisulfate is considered a moderate skin sensitiser according to the relative skin sensitisation potency classification scheme published in the ECETOC technical report on contact sensitisation (see reference 19).",,,,"0, 1, 3, 10, 15%",,"99.7 % (HPLC, 210 nm); 99.8% (HPLC 224 nm); 100.0 % (HPLC 254 nm)","ethanol was selected as the vehicle because of the good solubility of 4,5-diamino-1-hexyl-1Hpyrazole dihydrochloride in this solvent. ",dtf654/074a-hay,"test substance: 4,5-diamino-1-hexyl-1H-pyrazole dihydrochloride (wr804026)",mouse/cba/j,,,f,,5/dose,"volume of 25 μl by topial application was applied to the surface of the ear animals were checked for morbidity/mortality daily on days 1 to 6. observations for clinical signs were carried out immediately prior to and post-dose on days 1 to 3 and then once per day after dosing. bodyweight was measured on days 1 and 6. at day 6, the mice received an intravenous injection of 250 μl solution containing 20 μCi of[3H]-methyl thymidine. Five hours later, the mice were euthanised, and the draining auricular lymph nodes were removed and collected in PBS. After preparing a single cell suspension for each mouse, cells were precipitated by 5% trichloro-acetic acid, and the radioactivity was determined (incorporation of [3H] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm). ",,,daily for three consecutive days,70% ethanol,2009,yes,"the llna was performed with 1-hexyl-1H-pyrazole-4,5-diamine dihydrochloride, i.e. the dihydrochlorde instead of the hemisulfate salt. 1-hexyl-1H-pyrazole-4,5-diamine dihydrochloride was positive in the llna with an EC3 value of 8.6%. the sensitising potential and potency are attributable to the free base component. therefore, the results of the llna carried out with the dihydrochloride salt can be used for the hazard assessment of 1-hexyl 4,5-diamine pyrazole sulfate. the EC3 value of the hemisulfate salt was calculated from the dihydrochloride salt by using the conversion factor of 0.91 to account for the different molecular weights. therefore, the calculated EC3 value for 1-hexyl 4,5-diamine pyrazole sulfate is 7.8%. based on the calculated EC3 value of 7.8%, 1-hexyl 4,5-diamine pyrazole sulfate is a moderate skin sensitiser.",18,"positive control: 35% (v/v) hca in acetone/olive oil 4:1 (aoo). positive control, hca, at a concentration of 35.0% in acetone: olive oil, induced a 10.6-fold increase in isotope incorporation in the draining auricular lymph nodes relative to the vehicle control. mean stimulation index above 3 validated the experimental conditions. ",,,
"1,3,5-triazine, 2,4,6-tris[1,1’-biphenyl]-4-yl-",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_070.pdf,in vivo,"no cutaneous reactions and no increase in ear thickness were observed in the animals of the treated groups. a positive lymphoproliferative response (SI >3) was noted at the concentration of 0.5%. however, as no positive response and no dose-response relationship were observed at the highest tested concentrations, this positive response could not be considered as biologically relevant. it is concluded that under these experimental conditions, the test item fat 65’080/a does not induce delayed contact hypersensitivity in the murine local lymph node assay.",,,,,,,,,,,"0.5, 1.0, 2.5, 5.0 or 10%",,>98,,eth50/129b,test substance: fat 65’080/a,mouse/cbj/a,,±8 weeks,f,,4,"test item was applied to the dorsum of both ears daily for 3 consecutive days followed by 2 days without treatment. on days 1, 2 and 3 as well as on day 6 (after sacrifice), thickness of the left ear of each animal of the vehicle and treated groups was measured using a micrometer. any irritation reaction (erythema and oedema) was recorded in parallel. preparation procedure: termination: on day 6, the mice were injected intravenously with 3H-TdR, and five hours later the mice were sacrificed, and the auricular lymph nodes were excised. isolation lymph nodes: excised and pooled for each experimental group by mechanical disaggregation in petri dishes with the plunger of a syringe. cell suspensions were washed with 15 mL of 0.9% NaCl, pellets resuspended in 0.9% NaCl for numeration of lymphocytes and determination of viability. centrifuged and precipitated with 5% tca (+4 °C) overnight. centrifuged and precipitated with 5% tca, addition of 3 mL Ultima GoldxR scintillation fluid (packard). ",25µl,,,propylene glycol (due to unsatisfactory solubility of the test item in acetone/olive oil and in dimethylformamide),,yes,,6 (subm 1),positive control: 25% α-hexacinnamaldehyde,,"this study was based on the design adopted by iccvam (interagency coordination committee on the validation of alternative methods, iccvam 1999) and ecetoc (technical report no. 78 skin sensitization testing: methodological considerations, brussels, december 1999), with the addition of the evaluation of local irritation.",
"1-hydroxyethyl-4,5-diamino pyrazole sulfate",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_079.pdf,in vivo,"1-hydroxyethyl 4,5-diamino pyrazole sulfate did not induce a biologically relevant immune response in local lymph nodes after dermal application up to the maximum test concentration of 10%","1.4, 1.7, 1.5, 1.8 (in dmso) and 0,9, 1.0, 0.8, 1.0 (in acetone/olive oil) at respectively 0.5%, 1.5%, 5%, 10% ",,,,,,does not pose a sensitising risk to consumers when used as intended,,,,"0, 0.5, 1.5, 5, 10%",,100 (254 nm),,gst 7-18099,"test substance: 1-hydroxyethyl 4,5-diamino pyrazole sulfate",mouse/strain cba/ca01ahsd,,,f,,5,,25µl,,once daily on three consecutive days,acetone/water (1:1) mixed with olive oil (4:1) and dimethylsulfoxide,,yes,maximum test concentration was too low for hazard identification,7 (subm 2),"positive control p-phenylenediamine (PPD) at 1% in DMSO was used in parallel under identical test conditions, stimulation index in dmso of positive control: 14.2.  on day 5, the mice received an intravenous injection of 250 µl phosphate buffered saline containing 20 µCi of [H3] methyl thymidine. five hours later, the mice were sacrificed by CO2-inhalation and the draining auricular lymph nodes were removed. after preparing a single cell suspension, cells were precipitated by TCA and the radioactivity was determined (incorporation of [H3] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm). the mean dpm per treated group was determined and the stimulation index (test item compared to the concurrent vehicle control) was calculated.",,,
"2,4-diaminophenoxyethanol dihydrochloride and sulfate",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_035.pdf,in vivo,"in 2,4-diaminophenoxyethanol dihydrochloride groups, a dose-related increase in stimulation index was observed, and the threshold positive value of 3 was exceeded at concentrations of 5 and 10%. in the absence of local irritation attributed to 2,4- diaminophenoxyethanol dihydrochloride, these lymphoproliferative responses were attributed to delayed contact hypersensitivity, and the EC3 value was calculated to be 3.2%. ",,,,,,,"under the conditions of this study, 2,4-diaminophenoxyethanol dihydrochloride induced delayed contact hypersensitivity in the murine local lymph node assay. based on the EC3 value obtained (3.2%), it was considered to be a moderate skin sensitiser. ",,,,,,98.7,"this vehicle was selected in a previous solubility study showing that 2,4- diaminophenoxyethanol dihydrochloride was non-soluble in other recommended vehicles, and that 10% (w/v) 2,4-diaminophenoxyethanol dihydrochloride in dmso was the maximal practicable concentration.",120022,"test substance: 2,4-diaminophenoxyethanol dihydrochloride ",mouse: cba/j,,,f,,4,"the test item 2,4-diaminophenoxyethanol dihydrochloride, dmso or alphahexylcinnamaldehyde was applied over the ears (25 µL per ear) of respective animals for three consecutive days designated as days 1, 2 and 3. after 2 days of resting (day 6), mice received a single intravenous injection of tritiated methyl thymidine (3 H-TdR). lymph nodes draining the application sites (auricular nodes) were sampled, pooled per group, and the proliferation of lymphocytes was evaluated by measuring the incorporation of 3 H-TdR. the values obtained were used to calculate stimulation indices (SI), and the EC3 was calculated (theoretical concentration resulting in a SI of 3). the irritant potential of the test item was assessed by measuring ear thickness on days 1, 2, 3 and 6","0.5, 1, 2.5, 5 and 10 % w/v",,"the test item 2,4-diaminophenoxyethanol dihydrochloride, DMSO or alphahexylcinnamaldehyde was applied over the ears (25 µL per ear) of respective animals for three consecutive days designated as days 1, 2 and 3. after 2 days of resting (day 6), mice received a single intravenous injection of tritiated methyl thymidine (3 H-TdR). ",dmso,,yes,,6,"a negative control group receiving the vehicle (dmso) alone, a positive control group receiving alpha -hexylcinnamaldehyde at 25% (v/v) in dmso. a si value of 8.5 was obtained in the alpha-hexylcinnamaldehyde positive control group. this value was indicative of lymphoproliferation and showed the adequate sensitivity of the test system and procedure used. ",this concentration(10%) was non-irritant in a preliminary test. ,,
"2,6-diaminopyridine",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_084.pdf,in vivo,,"3.4, 3.4, 5.3 at respectively 0.25, 0.5, 1% ",,,,,,"strong sensitizer under the conditions in the present study, and the concentration of the test substance which induced an SI value of 3 was estimated to be 0.25% w/v",,,,"0.25, 0.50 and 1.0% w/v",,99.7,,a3221,,mouse/cba/jncrlj [spf],,,f,,4,,"0, 0.25, 0.50 and 1.0% w/v",,,acetone: olive oil (4:1),2006,yes,"an EC3 value of 0.09% was derived from the data. 2,6-diaminopyridine is an extreme sensitiser",5,"positive control: α-hexylcinnamaldehyde, 25% v/v and the SI value of the positive control group was 18.6. ",,"study consisted of 5 groups, including 3 doses of 2,6-diaminopyridine, no-treatment, and 25% v/v α-hexylcinnamaldehyde",
"hydroxyethyl-3,4-methylenedioxyaniline HCl",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_006.pdf,in vivo,"animals were checked for morbidity/mortality at least once daily. observation for clinical signs was done daily before and at least once after dosing. body weight was determined at day -1 and at day 5. slight to severe skin desquamation on the ears was noted in animals treated with hydroxyethyl-3,4-methylenedioxyaniline HCl at 1.5 % in dmso at day 5. this effect was associated with erythema in one animal. this effect was interpreted as being due to the low pH value of the hydroxyethyl-3,4-methylenedioxyaniline HCl solution. an EC3 value (equal to the concentration inducing a stimulation index of 3) was not calculated, since all stimulation indices were above 3. however, an EC3 value well below 0.5 % can be deduced from these findings. in the second vehicle (aqua/acetone/olive oil), an EC3 value was not calculated, since all stimulation indices were above 3, but as for dmso an EC3 < 0.5 % can be deduced from the data obtained. the responses noted in both groups are considered positive and indicate a skin sensitising potential of hydroxyethyl-3,4-methylenedioxyaniline HCl. ","6.4, 5.0, 8.0 and 12.4 for respectively 0.5, 1.5, 5 and 10 % in dmso; 4.3, 3.6, 3.3 and 4.4 for respectively 0.5, 1.5, 5 and 10 % in aqua/acetone/olive oil",,,,,,"induced a biologically relevant immune response in local lymph nodes after dermal application to the mouse ear with both vehicles tested. evaluated to be a strong skinsensitiser under the described test conditions, with an EC3 value below 0.5 %.",,,,"0.5, 1.5, 5.0, 10.0",,99.7,"a sufficient solubility and stability of the test item in the solvents used (dmso, acetone/water) is assumed.",9/93 (ems),,mouse/strain cba/j,,,f,,5,"substances applied to the surface of the ear. after application, the ears were dried by means of a hairdryer for about 5 minutes. . at day 5, the mice received an intravenous injection of 250 µl phosphate buffered saline containing 23.5 µCi of [H3] methyl thymidine. approximately five hours later, the mice were killed by CO2-inhalation and the draining auricular lymph nodes removed and weighed. after preparing a single cell suspension for each mouse, cells were precipitated by TCA and the radioactivity was determined (incorporation of [H3] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm)","0 (vehicles only), 0.5, 1.5, 5 and 10 %",,three consecutive days.,dmso and in {aqua/acetone (1:1)} / olive oil (3:1),,yes,"three further skin sensitisation tests, two maximisation tests according to magnusson and kligman and a buehler-test, have been performed with hydroxyethyl-3,4- methylenedioxyaniline HCl. as these tests have several limitations, they are not discussed but confirm the sensitising potential of the substance",20,positive control: p-phenylenediamine (PPD) at 1 % in dmso.  SI:12.5,,,
hc yellow n° 7,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_032.pdf,in vivo,"no irritation reactions, no lymphoproliferative responses, and the threshold SI of 3 values was not approached in any of the groups.","0.87, 0.77, 1.21,1.41, 1.44, 5.22 at respectively 1, 2.5, 5, 10, 25 and pos. control",,,,,,did not induce delayed contact hypersensitivity,,,,"1, 2.5, 5, 10 or 25% (w/v)",,97.3,"this vehicle was selected on the basis of the results from a previous solubility study showing that hc yellow n° 7 was non-soluble in other recommended vehicles, and that 25% (w/v) in dmf was the maximal practicable concentration. this concentration was non-irritating in a preliminary test.",509831,,mouse/cba/j,,,f,,4,"the test substance hc yellow n° 7, dmf or hca was applied on the ears (25 µL per ear) of the animals for 3 consecutive days designated as days 1, 2 and 3. after 2 days of resting (day 6), mice received a single intravenous injection of tritiated methyl thymidine (3 H-TdR). lymph nodes draining the application sites (auricular nodes) were sampled, pooled per group, and the proliferation of lymphocytes was evaluated by measuring the incorporation of 3 H-TdR. the values obtained were used to calculate stimulation indices (SI), and the EC3 was estimated (theoretical concentration resulting in a SI of 3). the irritant potential of hc yellow n° 7 was assessed by measuring ear thickness on days 1, 2, 3 and 6. ","0, 1, 2.5, 5, 10 or 25% (w/v)",,"daily, for 3 consecutive days",dimethylformamide (DMF),2004,yes,hc yellow n° 7 is a non-sensitiser in the llna,4,positive control: α-hexylcinnamaldehyde (hca) at 25% (v/v) in dmf. a negative control group receiving the vehicle (dmf) alone. ,,,
"2,6-dihydroxyethylaminotoluene",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_188.pdf,in vivo,no  symptoms of local toxicity at the ears of treated mice and no systemic findings were observed during the study period. the stimulation index (S.I.) was below 3 in all dose groups. no dose response relation was noted.,"2,6-di-(2- hydroxyethylamino)toluene; concentration %: 10 stimulation index: 1.2, concentration %: 25 stimulation index: 1.0, concentration %: 50 stimulation index: 0.9. alpha-hexylcinnamic aldehyde; concentration %: 5 stimulation index: 1.5, concentration %: 10 stimulation index: 2.9, concentration %: 25 stimulation index: 6.1.",,,,,,"2,6-di-(2-hydroxyethylamino)toluene is not a sensitiser. ",,,,,,99.7,,pvs 11/02 ,"test substance: 2,6-di-(2-hydroxyethylamino)toluene ","mouse/cba strain, inbred, spf-quality ",,,f ,,5,"by topical application to the dorsum of each ear lobe (25 µL) on three consecutive days. a control group of four mice was treated with the vehicle (ethanol:water (7:3 v/v)) only. five days after the first topical application the mice were injected intravenously into a tail vein with 3H-methyl thymidine. a pproximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. the proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter. ","0, 10, 25 and 50% ",,"three groups of five female mice each were treated with 2,6-di-(2- hydroxyethylamino)toluene at concentrations of 10, 25 and 50 % in ethanol:water by topical application to the dorsum of each ear lobe (25 µL) on three consecutive days. a control group of four mice was treated with the vehicle (ethanol:water (7:3 v/v)) only. five days after the first topical application the mice were injected intravenously into a tail vein with 3H-methyl thymidine. ",ethanol:water (7:3 v/v),7 – 21 june 2005 ,yes,,7 (submission 2),"positive control: alpha-hexylcinnamic aldehyde (in acetone:olive oil 4:1), control group of 4mice, ",,"local lymph node assay (LLNA), test animals were nulliparous and non-pregnant.",
2-amino-5-ethylphenol HCl ,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_085.pdf ,in vivo,"animals were checked for morbidity/mortality at least once daily. observation for clinical signs was done before and once per day after dosing. body weight was determined at day - 1 and day 5. at day 5, the mice received an intravenous injection of 250 µl solution containing 22.6 µCi of [H3] methyl thymidine. approximately 5 h later, the mice were sacrificed, and the draining auricular lymph nodes were removed and collected in PBS. after preparing a single cell suspension for each mouse, cells were precipitated by 5% trichloro-acetic acid (TCA), and the radioactivity was determined (incorporation of [H3] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm). the positive control ppd at a concentration of 1% in dmso gave a mean stimulation index of 6.6. in dmso, 2-amino-5-ethylphenol phosphate was positive in the local lymph node assay, as there was more than 3-fold increase in isotope incorporation in the draining auricular lymph nodes relative to the vehicle. the mean stimulation indices were 1.3, 2.1, 1.8 and 4.9 at the concentrations of 0.5%, 1.5%, 5.0% and 15.0%, respectively. the EC3 value was 8.9% in DMSO. in acetone/water/olive oil, 2-amino-5-ethylphenol phosphate was negative in the local lymph node assay, as there was less than a 3-fold increase in isotope incorporation in the draining auricular lymph nodes relative to the vehicle. the mean stimulation indices were 0.9, 1.2, 1.2 and 1.3 at the concentrations of 0.5%, 1.5%, 5.0% and 15.0%, respectively. an EC3 value could therefore not be calculated. ","in dmso: the mean stimulation indices were 1.3, 2.1, 1.8 and 4.9 at the concentrations of 0.5%, 1.5%, 5.0% and 15.0%, respectively with an EC3 8.9%. in water/acetone: the mean stimulation indices were 0.9, 1.2, 1.2 and 1.3 at the concentrations of 0.5%, 1.5%, 5.0% and 15.0%, respectively no EC3 could be calculated",,,,,,"2-amino-5-ethylphenol phosphate is a moderate skin sensitiser under the defined experimental conditions in dmso, with an EC3 value of 8.9% (corresponding to 6.6% HCl salt) and is not a skin sensitiser under the defined experimental conditions in acetone/water mixed with olive oil. considering the calculated EC3 value of the phosphate salt of 2-amino-5-ethylphenol in dmso, the EC3 value of the hydrochloride salt was calculated by using the correction factor related to the different free base content of the phosphate and the hydrochloride salt. EC3 value phosphate-salt: 8.9% 8.9% = 8.9 g/100 ml x 0.738 (correction factor) = 6.6 g /100 ml = 6.6% EC3 value hydrochloride-salt: 6.6%. based on this calculation, 2-amino-5-ethylphenol hydrochloride is considered as a moderate skin sensitiser.",,,,,test substance in dmso and in water/acetone (1:1) mixed with olive oil (3:1),99.9 ,,gst 079-03/33-08,test substance: 2-amino-5-ethylphenol phosphate ,mouse/strain cba/j ,,,f ,,5,,"0, 0.5, 1.5, 5.0 and 15.0% in dmso and 0, 0.5, 1.5, 5.0 and 15.0% in acetone/water/olive oil ",,"once daily, for three consecutive days",dmso and water/ acetone (1:1) mixed with olive oil at a ratio of 3:1,2005,yes,,23,positive control:  p-phenylenediamine (PPD) at 1% in dmso was investigated in parallel under identical test conditions. ,,local lymph node assay (LLNA),
basic brown 17,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_086.pdf,in vivo,"no clinical signs were observed in any animals of the control groups. on the third application day, a slight erythema was observed at both dosing sites in all mice of the 3%- group. from the second application day, a moderate or slight erythema was observed at both dosing sites in all mice of 6%-group, persisting for the remainder of the in-life phase of the study. no test item related findings, such as significant body weight loss or local/systemic findings were observed up to the concentration of 1 %. at the higher concentrations tested, i.e. 3 and 6%, some test item related signs, such as slight to moderate ear erythema, were observed at the local dosing sites but no clear change of dpm/LN was caused by this local irritant effect. all treated animals survived the scheduled study period. ",concentration (%): s.i.; test item 0.2: 1.0; 0.5: 1.0; 1: 1.3; 3: 0.9; 6: 1.3; α-hexylcinnamaldehyde 5: 2.4; 10: 3.6; 25: 11.2,,,,,,"the test item did not show an allergenic potential when tested up to the concentration of 6 % (w/v) in ethanol/water (7/3, v/v). ",,,,,,77.4 ,6% was the highest technically applicable concentration in the vehicle.,64960101,test substance: b007 (basic brown 17) ,mouse/cba/cahsdrcc (spf) ,,,f,,4,,"0.2, 0.5, 1, 3, 6 %",25µl,"daily with 0.2, 0.5, 1, 3 and 6% (w/v) in ethanol/water (7/3, v/v) by topical application to the dorsum of each ear lobe (left and right) for three consecutive days.","ethanol/water  7/3, v/v ",2005,yes,the vehicle used is not a recommended vehicle for llna. the maximum test concentration is too low. a conclusion on sensitisation cannot be drawn.,8,"3 positive control group of four mice treated with: 5, 10 and 25% (w/v) α-hexylcinnamaldehyde in acetone:olive oil (4:1,v/v). two negative control group treated with the vehicle only (ethanol/water (7/3, v/v))",,"taken from sccp/1173/08. local lymph node assay (llna). method of analysis: β-scintillation counter. Total number of animals: 28 (5 test groups, 2 negative control groups)",
hc blue n° 15,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_089.pdf,in vivo,"morbidity/mortality checks were performed twice daily. clinical examinations were performed daily. Individual body weights were recorded on days -1 and 5. all animals were sacrificed on day 5 for the assessment of cell proliferation. no mortality was observed during the study. there were no treatment-related clinical signs. there were no treatment-related effects on body weight or body weight gains. the test substance induced a negative response, as it did not elicit a least a 3-fold increase in isotope incorporation relative to the vehicle. ","the mean stimulation indices were 1.0, 1.7, 2.3 and 1.9 at the concentrations of 0.5%, 1.5%, 3.0% and 5.0%, respectively. ",,,,,,"based of these results, the test substance is not a skin sensitizer under the defined experimental conditions. ",,,,,,see comments on analytical characterisation ( batch purity),,bb77-020420,test substance: hc blue n° 15,mouse: cba/j,,,f,,5,,"0.5, 1.5, 3, 5 % (w/v)",2.5 μl ,"on days 0, 1 and 2 on the dorsal surface of each pinnae ",dmso,,yes,"the highest test concentration was too low. therefore, sensitising potential has not been excluded. ",21,"positive control: p-phenylenediamine. positive control (p-phenylenediamine) induced a positive response, as it elicited at least a 3-fold increase in isotope incorporation relative to the vehicle. the mean stimulation index was 3.9 at the concentration of 1%. ",,,
disperse violet 1,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_028.pdf,in vivo,ec3: 3.75%. ,"test item 0.5%: si 1.3, 1.5%: si 2.7, 4.5%: si 3.1, 9%: si 4.1",,,,,,disperse violet 1 is a skin sensitizer. ,,,,"0.5, 1.5, 4.5, 9",,97.9,,mb002,test substance: disperse violet 1,mouse: cba/j,,,f,,20,,"0.5, 1.5, 4.5, 9 % (w/v) ",25 μl,topical on dorsal surface of each ear,dmso,2002,yes,"according to the grading scheme used by sccs (sccp/0919/05), disperse violet 1 is a moderate skin sensitiser. ",20 (subm. 2),"positive control: 1% p-phenylenediamine, si at 1%: 6.4",,"all animals received an intravenous injection (Infusion pump) of 250 μl of pbs containing 20 μCi of [3H] methyl thymidine. 5 hours later the animals were sacrified, the auricular lymph node taken and weighed and a single cell suspension obtained from each animal. ",
hc red n° 16,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_045.pdf,in vivo,"no clinical signs were observed in any animals of the control group and the low and mid dose group. on the second application day, all mice of the high dose group excreted deep yellow urine, persisting for a total of three days.",si was above 3 in all dose groups. no dose response relation was noted. test item concentration (% (w/v)) – s.i.: 5 – 3.0 / 10 – 3.9 / 25 – 3.8;  ec3: about 5%; ,,,,,,hc red n° 16 was found to be a moderate sensitizer when tested in acetone:olive oil (4:1) in mice.,a homogenous dilution of the test item in a mixture of acetone:olive oil (4:1 v/v) was made shortly before each dosing. ,,,,the test item in the vehicle,99.4,,ro-rn6794-107,test substance: hc red n°16 ,mouse/ cba/caOlaHsd,,,f,,4,,"5, 10, 25%",25 μl,topical on dorsal surface of each ear, acetone:olive oil (4:1 v/v),2004,yes,,8,positive control: α-hexylcinnamaldehyde. the control group was treated with the vehicle exclusively. positive control (% (w/v)): 5 – s.i 1.5 / 10 – s.i 2.3 / 25 – s.i 8.4. ec3 positive control: about 11.7%,"the highest technically applicable test item concentration of 25% was found to be non-irritating in a pretest with two female mice. based on these test results 5%, 10% and 25% solutions were chosen for the main study. ",,radiochemical: thymidine (3HTdR)
hc red n° 17,OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_182.pdf,in vivo,"the validity criteria were fulfilled. in particular, a si value of 5.21 was obtained with the positive control hca. si values of 1.42, 1.53, 1.75, 2.36 and 2.55 were obtained at hc red n° 17 concentrations of 1%, 2.5%, 5%, 10% and 25%, respectively. ",,,,,,,"under the conditions of this study, hc red n° 17 did not induce delayed contact hypersensitivity and was therefore considered to be devoid of sensitising potential. ",,,,,,88.5 +/- 0.6,"due to unsatisfactory solubility tests of hc red no. 17 in the first recommended vehicles, dmso was selected. a solubility study showed that 50% (w/v) hc red no. 17 in dmso was the maximal achievable concentration.",039 d 001 ,test substance: hc red n° 17 (b120),mouse/cba/j,,,f,,4,,"0, 1, 2.5, 5, 10, 25 % (w/v) solutions",25 μl,,dmso,2012,yes,hc red n° 17 induced a dose-dependent increase of lymphocyte proliferation in the llna that resulted in a si value of 2.55 at the highest dose (25%) tested. hc red n° 17 is not considered to be a skin sensitiser under the conditions of the test. ,4,"a negative control group receiving the vehicle (dmso) alone. - a positive control group receiving alpha-hexylcinnamaldehyde (hca) at 25% (v/v) in
dmso."," the pre-test showed that treatment with 50% hc red n° 17 caused a 40% increase in ear thickness, and this concentration therefore was not selected for the main study.","test procedure: animals were separated in 7 groups (4 mice/group) consisting of: - 5 treated groups receiving hc red n° 17 at 1, 2.5, 5, 10 or 25% (w/v) in dmso. - due to unsatisfactory solubility tests of hc red n° 17 in the first recommended vehicles, dmso was selected. - the pre-test showed that treatment with 50% hc red n° 17 caused a 40% increase in ear thickness, and this concentration therefore was not selected for the main study. - ",
bis(butylbenzoate) diaminotriazine aminopropyltrisiloxane ,OECD TG 429 / EC B.42,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_055.pdf,in vivo,"no mortality and no clinical signs were observed during the study. among the different concentrations of test item applied, the highest concentration (25%) revealed to be slightly irritant based on an increase in ear thickness. ","for the different test concentrations of 1%, 2.5%, 5%, 10% and 25%, SI-values of 0.81, 1.06, 0.97, 1.12, and 2.32 were derived, respectively, whereas the positive control yielded a SI of 14.71. thus, stimulation indices of the test item did not exceed 3 for any of the concentrations tested.",,,,,the highest concentration (25%) revealed to be slightly irritant based on an increase in ear thickness. ,"under the experimental conditions of this study, the test item r0027603a did not induce contact sensitization in the murine local lymph node assay. ",,,,,r0027603a,98.2,,pilote 2,test substance: r0027603a ,mouse/ cba/j,,,f,,4,,"1, 2.5, 5, 10, 25 % [w/v] of test item in AOO",25 μl,"route: application to the dorsal surface of both ears on days 1, 2 and 3",acetone/olive oil ,2009,yes,,5,negative control: vehicle only; positive control: 25% (v/v) α-hexylcinnamaldehyde (HCA) in AOO,"for the preliminary test (performed in order to select doses for the main study), 25 μl of test item at concentrations of 5, 10, 25 and 50% in vehicle were applied to the external surface of both ears for three consecutive days. ear thickness was determined using a micrometer the day before treatment, during each treatment day and 72 hrs after the last application. as an increase in ear thickness was noted on day 6 at the 50% concentration, a concentration of 25% was selected as the highest dose for the main study. 1 animal in preliminary test",,
"2,7-naphthalenediol",OECD 429,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_034.pdf,in vivo,the ec3 value calculated from these data was 2.8%. ,treatment - induction - mean dpm ± sd - si ± sd / vehicle control - acetone : olive oil - 213 ± 170 - 1.0 / experimental - 5% hexylcinnamaldehyde (hca) - 250 ± 171 - 1.2 ± 1.0 / experimental - 10 % hca - 580 ± 365 - 2.7 ± 1.0./ experimental - 25% hca - 3575 ± 1207 - 16.8 ± 0.9 /experimental - 0.5% test substance - 218 ± 139 - 1.6 ± 0.7/ experimental - 1.0% test substance - 241 ± 147 - 1.8 ± 0.7 / experimental - 2.5% test substance - 191 ± 34 - 1.4 ± 0.3 / experimental - 5.0% test substance - 684 ± 440 - 4.5 ± 0.9 / experimental - 25% test substance - 1878 ± 416 - 12.4 ± 0.7 / experimental  - 50% test substance - 632 ± 151 - 4.2 ± 0.7 / vehicle control - acetone : olive oil (4:1 v/v) - 151 ± 94 - 1.0 / vehicle control - acetone : olive oil (4:1 v/v) - 134 ± 40 - 1.0,,,,,,"the results indicate that 2,7-naphthalenediol is a moderate skin sensitiser. ",,,,"0.5, 1.0, 2.5, 5.0, 25, 50 (w/v) ",,99.9,,20020517,"test substance: 2,7-naphthalenediol",mouse/cba caolahsd,,10-11 weeks,f,,5,,,25 µl,25 µl of test material or vehicle control and positive control was applied to the dorsal surface of both ear lobes once daily for 3 consecutive days. 5 days after the first application animals were injected iv with 250µl 3 H-methyl thymidine in the tail vein. mice were sacrificed 5 hours later. ,acetone:olive oil 4:1 (v/v),,yes,,6,"positive control: alpha-hexylcinnamaldehyde (5, 10 and 25%), vehicle control: acetone/olive oil (4:1, v/v).",,llna: local lymph node assay,